Welcome to our dedicated page for XY Labs SEC filings (Ticker: XYLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on XY Labs's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into XY Labs's regulatory disclosures and financial reporting.
XY Labs, Inc. effected a one-for-ten-thousand (1:10,000) reverse stock split of its Class A and Class B common stock effective March 31, 2026. Every 10,000 pre-split shares were combined into one post-split share. Fractional shares will be cashed out at $0.08 per share, as set by a third-party valuation and approved by the Board.